Penumbra Inc

PEN

New York Stock Exchange. Currency in USD

216.20 -12.07 ( -5.29% )

Real time prices: December 09

Market Cap.
8.21B
Beta (5Y monthly)
0.51
Price/Earnings
2.60
EPS (TTM)
81.16
Forward Dividend
0.00 (0.00%)
Ex-Dividend Date
Volume
375,487
1y Target Est.
210.40
Day's Range
216.19
-
230.94
52 Week's Range
114.86
-
290.36

Historical Summary

Performance
EPS growth
Share Buybacks

About Penumbra Inc

Sector
Healthcare
Industry
Medical Devices
Website
https://www.penumbrainc.com
Exchange
New York Stock Exchange (XNYS)
Shares Outstanding
37.36M
Employees
3800
Address
One Penumbra Place, Alameda, CA, United States, 94502
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand, as well as immersive computer-based technologies and immersive therapeutics to promote health, motor function, and cognition under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Latest news

What 8 Analyst Ratings Have To Say About Penumbra
What 8 Analyst Ratings Have To Say About Penumbra

Analysts have provided the following ratings for Penumbra (NYSE:PEN) within the last quarter: Bullish Somewhat...
By Benzinga - 4 days ago

What 6 Analyst Ratings Have To Say About Penumbra
What 6 Analyst Ratings Have To Say About Penumbra

Penumbra (NYSE:PEN) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish...
By Benzinga - 5 weeks ago

Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022
Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022

Upgrades Citigroup upgraded the previous rating for Advanced Energy Industries Inc (NASDAQ:AEIS) from Neutral to...
By Benzinga - 5 weeks ago

Under Armour To Rally Over 13%? Here Are 5 Other Price Target Changes For Friday
Under Armour To Rally Over 13%? Here Are 5 Other Price Target Changes For Friday

Telsey Advisory Group raised Under Armour, Inc.. (NASDAQ: UAA) price target from $8 to $9....
By Benzinga - 5 weeks ago

Analysts Estimate Penumbra (PEN) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Penumbra (PEN) to Report a Decline in Earnings: What to Look Out for

Penumbra (PEN) doesn't possess the right combination of the two key ingredients for a likely...
By Zacks Investment Research - 6 weeks ago

What 8 Analyst Ratings Have To Say About Penumbra
What 8 Analyst Ratings Have To Say About Penumbra

Penumbra (NYSE:PEN) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish...
By Benzinga - 8 weeks ago

Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022

Upgrades For CME Group Inc (NASDAQ:CME), Deutsche Bank upgraded the previous rating of Hold to...
By Benzinga - 8 weeks ago

Analyst Ratings for Penumbra
Analyst Ratings for Penumbra

Analysts have provided the following ratings for Penumbra (NYSE:PEN) within the last quarter: Bullish Somewhat...
By Benzinga - 9 weeks ago